De Forni M - Search Results

1

[Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].

Chatelut E, Canal P, De Forni M, Chevreau C, Houin G, Bugat R. Chatelut E, et al. Among authors: de forni m. Bull Cancer. 1989;76(8):893-6. Bull Cancer. 1989. PMID: 2620120 French. No abstract available.

2

Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.

Chatelut E, de Forni M, Canal P, Chevreau C, Roche H, Plusquellec Y, Johnson NP, Houin G, Bugat R. Chatelut E, et al. Among authors: de forni m. Ann Oncol. 1991 Mar;2(3):217-21. doi: 10.1093/oxfordjournals.annonc.a057910. Ann Oncol. 1991. PMID: 2043492 Free article. Clinical Trial.

3

[Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].

de Forni M, Bugat R, Sorbette F, Delay M, Bachaud JM, Chevreau C. de Forni M, et al. Bull Cancer. 1990;77(5):429-38. Bull Cancer. 1990. PMID: 2205312 Review. French.

4

[Comparison of the pharmacokinetics of cisplatin administered by the intraperitoneal route in 2 dosages: 100 and 200 mg/m2].

Canal P, Chatelut E, De Forni M, Chevreau C, Johnson N, Houin G, Bugat R. Canal P, et al. Among authors: de forni m. Bull Cancer. 1989;76(8):879-82. Bull Cancer. 1989. PMID: 2620116 French. No abstract available.

5

Anatomic changes in the abdominal cavity during intraperitoneal chemotherapy: prospective study using scintigraphic peritoneography.

de Forni M, Boneu A, Otal P, Martel P, Shubinski R, Bugat R, Lucot H. de Forni M, et al. Bull Cancer. 1993 Apr;80(4):345-50. Bull Cancer. 1993. PMID: 8173187

6

[Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers].

de Forni M, Gualano V, Canal P, Martel P, Izar-Soum F, Chevreau C, Soulié P, Roché H, Bugat R. de Forni M, et al. Bull Cancer. 1993 May;80(5):408-17. Bull Cancer. 1993. PMID: 8173194 Clinical Trial. French.

7

[Intraperitoneal high dose chemotherapy as consolidation treatment for advanced ovarian carcinoma: a pilot study].

Gladieff L, Chatelut E, Gaspard MH, Skaf R, de Forni M, Mihura J, Canal P, Bugat R. Gladieff L, et al. Among authors: de forni m. Bull Cancer. 1999 Jul-Aug;86(7-8):673-7. Bull Cancer. 1999. PMID: 10477384 Free article. French.

8

Human pharmacokinetics of N-L-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities.

Canal P, Robert J, Ramon M, Baurain R, Tresca P, de Forni M, Marty M, Pujade-Lauraine E, Bugat R, Magis A, et al. Canal P, et al. Among authors: de forni m. Clin Pharmacol Ther. 1992 Mar;51(3):249-59. doi: 10.1038/clpt.1992.19. Clin Pharmacol Ther. 1992. PMID: 1544285 Clinical Trial.

9

Phase I/II pharmacokinetic study of mitoxantrone by continuous venous infusion in patients with solid tumours and lymphoproliferative diseases.

de Forni M, Lachau S, Huguet F, Canal P, Laurent G, Chevreau C, Roche H, Bugat R. de Forni M, et al. Eur J Cancer. 1991;27(6):735-9. doi: 10.1016/0277-5379(91)90177-f. Eur J Cancer. 1991. PMID: 1829914

10

Chronopharmacokinetics of doxorubicin in patients with breast cancer.

Canal P, Sqall A, de Forni M, Chevreau C, Pujol A, Bugat R, Roche H, Oustrin J, Houin G. Canal P, et al. Among authors: de forni m. Eur J Clin Pharmacol. 1991;40(3):287-91. doi: 10.1007/BF00315211. Eur J Clin Pharmacol. 1991. PMID: 2060566 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters